A Busy Week for Company Meetings and New IPOs

An array of corporate events is scheduled, including earnings calls, analyst presentations, roadshows, and more. One of such is NetApp Inc’s meeting, sponsored by the associated firm, planned for today at 18:30. Anticipate various conventions and conference calls, from business entities such as Sunrise Realty Trust and HubSpot, happening earlier on the next day. TechTrek 2025 conference as well is on the agenda at David Kempinski Hotel, Tel Aviv.

Worthy of acknowledgment is the BTIG Private Company Conference taking place in Napa Valley and the Best Ideas Growth (BIG9) Conference happening in New York city. Also in line is the 4th Annual Growth Frontiers Conference scheduled in Nashville, followed by the Casino Tours Conference in St. Louis. The Envista sponsored firm meeting is also featured as part of Tomorrow’s schedule in Boston.

Other sponsored meetings to look forward to include Prog Holdings in New York. Beyond these meetings, the appraisal of upcoming Initial Public Offerings (IPOs) and secondary offerings for the week could be crucial. Regarding these events, the anticipated IPOs will be presented, whether they are not priced, and if they presently have initial costs.

A few of these offerings were already priced. For instance, ZGMXZGM Zenta initiated their IPO under the management of Cathay with shares priced at $4.00 totaling to 1.5M. In a similar fashion, Fox Corp., having their spot secondary managed by Morgan Stanley, offered shares priced at $54.25 amounting to approximately 16.835M.

Kodiak Gas Services, managed by Golden Sachs, initiated a spot secondary offering of their shares at $34.40 and a total of 10M shares. News Corp. also advertised a spot secondary share count of 14.07M at an offering price of $32.45 with Morgan Stanley at the helm.

Marked for Tuesday, Nuveen Churchill is offering a block trade with Morgan Stanley as managers, having shares amounting to 948K priced at $15.38. Additionnaly, Klarna’s IPO, managed by several firms including Goldman Sachs, JPMorgan and Morgan Stanley, is pricing their 34.31M shares at a rate of $40.00.

Actuate Therapeutics plans a secondary offering managed by LICD and Titan Partners, offering its 2.142M shares at $7.00. On its end, Dianthus seeks to initiate a secondary maneuver with Jefferies, TD Cowen, and Evercore ISI in charge, featuring 6.49M shares at $33.00.

Rapport Therapeutics lists a secondary offering of 9.62M shares at a price of $26.00 under Goldman Sachs, Jefferies, TD Cowen, and Stifel as managers. Amylyx is offering a spot secondary of 17.5M shares at $10.00 with H.C. Wainwright handling the operations.

Lucid Diagnostics is contributing a spot secondary of 25M shares going for $1.00, with Canaccord, BTIG, and Maxim managing the operations. The week’s proceeding is slated for a calm period as no deals are expected on Wednesday, Thursday and Friday of the following week.

Rise Smart Group is set to initiate an IPO early the next week with American Trust and Prime Number as amangers, showcasing 1.8M shares at a cost of $4.00. Figure’s IPO is to be managed by several firms including Goldman Sachs and Jefferies, offering 31.5M shares ranging between $20.00-22.00.

LB Pharmaceuticals also intends to launch an IPO with Leerink, Piper Sandler, and Stifel at the helm, offering 16.67M shares at a price range of $14.00-16.00. Regentis Biomaterials is launching its own IPO offer of 1M shares priced between $10.00-12.00, thoughtfully managed by ThinkEquity.

Airo Group’s secondary offering is introducing 3.5M shares at $20.50 with Cantor Fitzgerald as the responsible manager. Holley is following suit with a secondary offering of 14M shares priced at $3.67, with JPMorgan and Jefferies managing the operations.

The entry of the Black Rock Coffee Bar into the IPO market is also expected to generate interest, with a list of heavyweight managers, including JPMorgan, Jefferies, and Morgan Stanley supporting their offer of 14.706M shares priced between $16.00-18.00. Also relevant is the planned IPO from Gemini, managed by Goldman Sachs, amongst others, and offering 16.67M shares priced between $24.00-26.00.

Looking forward, Legence IPO under Goldman Sachs supervision, offers 26M shares ranging between $25.00-29.00. In similar fashion, Via Transportation is launching its IPO with 10.714M shares priced at a range of $40.00-44.00. Secondary shares by Avidity Biosciences will be available too, with 5M shares at $46.40. Notably, the end of week comes with no scheduled deals.